Renowned physician and researcher Guido Marcucci, MD, has joined City of Hope in a key leadership role within the institution’s new Hematologic Malignancies and Stem Cell Transplantation Institute. As Director of the Gehr Family Center for Leukemia Research and as Chief of the Division of Hematopoietic Stem Cell and Leukemia Research, Dr. Marcucci will guide research into improved treatments for leukemia and other hematologic malignancies.
Dr. Marcucci, who will also serve as Professor of Hematology & Hematopoietic Cell Transplantation, joins City of Hope from Ohio State University, where he was Professor of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, and Pharmaceutics in the Division of Hematology at the University’s Comprehensive Cancer Center. At City of Hope, he will head one of six cornerstone centers in the institution’s recently launched hematologic institute, setting scientific priorities and guiding the development of new approaches to treating leukemia and related diseases, especially those involving hematopoietic stem cell transplantation.
“City of Hope is extremely fortunate to have a scientist and physician of Dr. Marcucci’s caliber and accomplishments as Chief of our new leukemia center,” said Steven T. Rosen, MD, Provost and Chief Scientific Officer at City of Hope. “With his guidance and vision, we will be able to develop and bring to fruition revolutionary new treatments for leukemia and other diseases.”
“I’m extremely pleased to join such a remarkable institution as it expands its commitment to developing new treatment approaches,” Dr. Marcucci said. ■
